Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Veliko Tirnovo – page 6

78 clinical trials in Veliko Tirnovo, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Veliko Tirnovo at a glance
78
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

78 trials in Veliko Tirnovo

Open in trial search

Colitis ulcerative

Not recruiting

Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.

Colitis ulcerative

Not recruiting

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Major depression

Not recruiting

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Bipolar disorder

Not recruiting

Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Schizophrenia

Not recruiting

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Valbenazine Ditosylate
  • Sponsor:Neurocrine Biosciences Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Emraclidine
  • Sponsor:Cerevel Therapeutics LLC

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tovinontrine
  • Sponsor:Cardurion Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Study on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Zelicapavir
  • Sponsor:Enanta Pharmaceuticals Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Veliko Tirnovo

What the registry says about research in the country

01 Cardiovascular Research

Extensive studies focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Research includes evaluation of new medications for reducing cardiovascular events and managing blood lipid levels.

  • Deep Vein Thrombosis Treatment
  • Stroke Prevention in Atrial Fibrillation
  • Heart Failure Management

Trials are investigating novel approaches to cholesterol management and prevention of major adverse cardiovascular events.

02 Respiratory Medicine

Advanced research into chronic obstructive pulmonary disease (COPD) treatments and respiratory infections. Studies evaluate new therapeutic combinations and treatment efficacy.

  • COPD Treatment Optimization
  • Respiratory Syncytial Virus Therapy
  • Lung Function Improvement

Focus on developing improved inhalation therapies and testing new drug formulations for respiratory conditions.

03 Gastroenterology Studies

Innovative research in treating ulcerative colitis and inflammatory bowel conditions. Multiple trials exploring combination therapies and long-term treatment options.

  • Moderate to Severe Ulcerative Colitis
  • Novel Treatment Combinations
  • Long-term Disease Management

Emphasis on developing sustainable treatment approaches for chronic gastrointestinal conditions.

04 Mental Health Research

Comprehensive studies on major depressive disorder and other psychiatric conditions. Investigation of new therapeutic approaches for mental health management.

  • Schizophrenia Treatment
  • Bipolar Disorder Management
  • Depression Therapy

Focus on long-term safety and efficacy of new psychiatric medications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.